Thank you for subscribing!
Finfeed Archived Apr 16, 2020
Mayne Pharma Group Limited (ASX: MYX) has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA), seeking marketing authorisation for E4/DRSP, a combined oral contraceptive indicated for the prevention of pregnancy.
Get expert stock analysis direct in your inbox
Join Our Mailing List
